MED Medifast Inc
- Stocks
- Consumer Cyclical
- NYSE: MED
Price (delayed)
$14.02
Market cap
$154.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.65
Enterprise value
$76.99M
Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a
Highlights
The company's quick ratio rose by 34% YoY and by 8% QoQ
Medifast's debt has decreased by 29% YoY and by 9% from the previous quarter
The EPS has dropped by 110% year-on-year
MED's net income has shrunk by 110% YoY
Key stats
What are the main financial stats of MED
Market
Valuations
Earnings
Shares outstanding
10.99M
Market cap
$154.09M
Enterprise value
$76.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
0.28
EV/EBIT
N/A
EV/EBITDA
14.87
EV/Sales
0.14
Revenue
$543.45M
Gross profit
$401.58M
Operating income
-$6.32M
Net income
-$7M
EBIT
-$12.08M
EBITDA
$5.18M
Free cash flow
$13.47M
Per share
Balance sheet
Liquidity
EPS
-$0.65
EPS diluted
-$0.65
Free cash flow per share
$1.23
Book value per share
$19.29
Revenue per share
$49.64
TBVPS
$25.58
Total assets
$280.01M
Total liabilities
$69.05M
Debt
$14.61M
Equity
$210.96M
Working capital
$152.93M
Debt to equity
0.07
Current ratio
3.52
Quick ratio
2.72
Net debt/EBITDA
-14.89
Margins
Efficiency
Dividend
EBITDA margin
1%
Gross margin
73.9%
Net margin
-1.3%
Operating margin
-1.2%
Return on assets
-2.4%
Return on equity
-3.4%
Return on invested capital
-9%
Return on capital employed
-5.5%
Return on sales
-2.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MED stock price
How has the Medifast stock price performed over time
Intraday
-2.09%
1 week
-7.82%
1 month
-0.21%
1 year
-33.87%
YTD
-20.43%
QTD
-0.21%
Financial performance
How have Medifast's revenue and profit performed over time
Revenue
$543.45M
Gross profit
$401.58M
Operating income
-$6.32M
Net income
-$7M
Gross margin
73.9%
Net margin
-1.3%
Medifast's net margin has plunged by 117% YoY
Medifast's operating margin has shrunk by 113% YoY
MED's net income has shrunk by 110% YoY
The operating income has shrunk by 108% YoY
Price vs fundamentals
How does MED's price correlate with its fundamentals
Growth
What is Medifast's growth rate over time
Valuation
What is Medifast stock price valuation
P/E
N/A
P/B
0.73
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
14.87
EV/Sales
0.14
The EPS has dropped by 110% year-on-year
MED's P/B is 91% below its 5-year quarterly average of 7.9 and 19% below its last 4 quarters average of 0.9
The P/S is 75% lower than the 5-year quarterly average of 1.1 and 7% lower than the last 4 quarters average of 0.3
MED's revenue is down by 39% year-on-year and by 10% since the previous quarter
Efficiency
How efficient is Medifast business performance
The return on sales has dropped by 123% year-on-year
The return on invested capital has dropped by 113% year-on-year
The ROA has plunged by 111% YoY
MED's ROE has shrunk by 110% YoY
Dividends
What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Medifast financials performed over time
The company's quick ratio rose by 34% YoY and by 8% QoQ
Medifast's total liabilities has decreased by 25% YoY and by 7% QoQ
Medifast's debt is 93% less than its equity
Medifast's debt to equity has decreased by 30% YoY and by 13% from the previous quarter
Medifast's debt has decreased by 29% YoY and by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.